LA JOLLA PHARMACEUTICAL CO (LJPC)
La Jolla Pharmaceutical Company, a biopharmaceutical company, engages in the research and development of technology and potential drugs to treat antibody-mediated diseases. It is developing Riquent as a treatment for Lupus nephritis, which is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. The company was founded in 1989 and is based in San Diego, California.
|Business Address:||4370 La Jolla Village Drive, Suite 400, San Diego, CA 92122-1249, United States|
|State of Inc:||CA|